Literature DB >> 2338163

Immunochemical quantitation of fatty acid-binding proteins. Tissue distribution of liver and heart FABP types in human and porcine tissues.

R J Paulussen1, H T van Moerkerk, J H Veerkamp.   

Abstract

1. Antisera against heart and liver fatty acid-binding proteins (FABPs) were used in enzyme-linked immunosorbent assay to study the cross-reactivity between these FABP types of man, pig and rat, and to assess their tissue distribution in man and pig. 2. No cross-reactivities were found of heart FABPs with anti-liver FABP sera and vice versa. With the liver FABPs, marked species differences were found, but the three proteins are clearly related. Human and pig heart FABP are immunochemically closer related to each other than to this protein from rat heart. 3. The tissue distribution of the heart and liver FABP types is similar in man, pig and rat. Liver FABP is only found in liver and intestine, and heart FABP is present in heart, skeletal muscle, kidney, lung, brain and placenta. 4. Cardiac FABP is also found in cultured human and rat endothelial cells. 5. The FABP content of human and pig liver is comparable to that of rat liver, but the tissue concentrations of heart FABP are lower in man and pig than in rat. When the latter values are expressed relative to the FABP content in heart, analogous distribution patterns are observed in man, pig and rat.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2338163     DOI: 10.1016/0020-711x(90)90142-p

Source DB:  PubMed          Journal:  Int J Biochem        ISSN: 0020-711X


  19 in total

1.  Structural and functional studies on different human FABP types.

Authors:  J H Veerkamp; H T van Moerkerk; C F Prinsen; T H van Kuppevelt
Journal:  Mol Cell Biochem       Date:  1999-02       Impact factor: 3.396

Review 2.  Detection, tissue distribution and (sub)cellular localization of fatty acid-binding protein types.

Authors:  J H Veerkamp; R J Paulussen; R A Peeters; R G Maatman; H T van Moerkerk; T H van Kuppevelt
Journal:  Mol Cell Biochem       Date:  1990 Oct 15-Nov 8       Impact factor: 3.396

3.  Human heart-type cytoplasmic fatty acid-binding protein as an indicator of acute myocardial infarction.

Authors:  K Yoshimoto; T Tanaka; K Somiya; R Tsuji; F Okamoto; K Kawamura; Y Ohkaru; K Asayama; H Ishii
Journal:  Heart Vessels       Date:  1995       Impact factor: 2.037

Review 4.  Cellular fatty acid-binding proteins: current concepts and future directions.

Authors:  J F Glatz; G J van der Vusse
Journal:  Mol Cell Biochem       Date:  1990 Oct 15-Nov 8       Impact factor: 3.396

5.  Characterization, chromosomal localization, and genetic variation of the porcine heart fatty acid-binding protein gene.

Authors:  F Gerbens; G Rettenberger; J A Lenstra; J H Veerkamp; M F te Pas
Journal:  Mamm Genome       Date:  1997-05       Impact factor: 2.957

6.  Characterization and binding properties of human fetal lung fatty acid-binding proteins.

Authors:  G Sa; T Das; M Mukherjea
Journal:  Mol Cell Biochem       Date:  1993-12-08       Impact factor: 3.396

7.  Fatty acid-binding proteinuria diagnoses myocardial infarction in the rat.

Authors:  P G Volders; M M Vork; J F Glatz; J F Smits
Journal:  Mol Cell Biochem       Date:  1993 Jun 9-23       Impact factor: 3.396

8.  Effect of clofibric acid on the turnover of the fatty acid-binding protein identified in cultured endothelial cells from bovine aorta.

Authors:  M Robers; B Loddenkötter; H Kresse; F Spener
Journal:  Lipids       Date:  1993-06       Impact factor: 1.880

9.  Transcriptional regulation of muscle fatty acid-binding protein.

Authors:  J O Carey; P D Neufer; R P Farrar; J H Veerkamp; G L Dohm
Journal:  Biochem J       Date:  1994-03-15       Impact factor: 3.857

10.  Molecular identification of the liver- and the heart-type fatty acid-binding proteins in human and rat kidney. Use of the reverse transcriptase polymerase chain reaction.

Authors:  R G Maatman; E M van de Westerlo; T H van Kuppevelt; J H Veerkamp
Journal:  Biochem J       Date:  1992-11-15       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.